Evidence map›Paper›PMID 25027322›Full record

ArticleHuman molecular genetics2014

The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Jason A Bonomo, Meijian Guan, Maggie C Y Ng, Nicholette D Palmer, Pamela J Hicks, Jacob M Keaton, Janice P Lea, Carl D Langefeld, Barry I Freedman, Donald W Bowden

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A novel interaction between RNA mBiochemical and biophysical research communications · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genome-wide identification of mOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jason A BonomoDepartment of Molecular Medicine and Translational Science, Center for Genomics and Personalized Medicine Research.
Meijian GuanCenter for Genomics and Personalized Medicine Research.
Maggie C Y NgCenter for Genomics and Personalized Medicine Research.
Nicholette D PalmerCenter for Genomics and Personalized Medicine Research, Department of Biochemistry.
Pamela J HicksCenter for Genomics and Personalized Medicine Research.
Jacob M KeatonCenter for Genomics and Personalized Medicine Research.
Janice P LeaDepartment of Internal Medicine - Nephrology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Carl D LangefeldCenter for Genomics and Personalized Medicine Research, Department of Biostatistical Sciences.
Barry I FreedmanCenter for Genomics and Personalized Medicine Research, Department of Internal Medicine - Nephrology, Wake Forest School of Medicine, Winston Salem, NC 27157, USA and.
Donald W BowdenCenter for Genomics and Personalized Medicine Research, Department of Biochemistry, dbowden@wakehealth.edu.
Biostatistical Consulting (United States) · USEmory University · USWake Forest University · US

Funding

Genetics of African American Type 2 DiabetesR01DK066358 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NG, MAGGIE · 2003 to 2019
$6.2M
MAPPING GENES FOR NIDDM NEPHROPATHY IN AFRICAN AMERICANSR01DK053591 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BOWDEN, DONALD W · 1998 to 2015
$5.6M
Genetic Analysis of African American Hypertensive End-Stage Renal DiseaseR01DK070941 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2006 to 2015
$4.7M
Subclinical CVD in African American Type 2 DiabeticsR01DK071891 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2007 to 2016
$4.5M
Genetic Determinants of Adiposity in African AmericansR01DK087914 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NG, MAGGIE · 2010 to 2014
$3.0M
Detection of Coding Variants Modulating Diabetic Nephropathy in African AmericansF30DK098836 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BONOMO, JASON ANDREW · 2013 to 2015
$135k
NIDDK NIH HHS F30 DK098836NIDDK NIH HHS R01 DK053591NIDDK NIH HHS R01 DK066358NIDDK NIH HHS R01 DK070941NIDDK NIH HHS R01 DK071891NIDDK NIH HHS R01DK071891NIDDK NIH HHS R01 DK087914NIDDK NIH HHS R01 DK53591
6 · The paper itself

Abstract

Familial clustering and presumed genetic risk for type 2 diabetic (T2D) and non-diabetic end-stage kidney disease (ESKD) appear strong in African Americans. Examination of exome sequencing data in African American T2D-ESKD cases and non-diabetic non-nephropathy controls identified two low-frequency variants in the RREB1 gene, a repressor of the angiotensinogen (AGT) gene previously associated with kidney function, as being associated with T2D-ESKD: rs9379084 (P = 0.00087, OR = 0.26; D1171N) and rs41302867 (P = 0.00078, OR = 0.21; splice site variant). Rs41302867 replicated association in an independent sample of African Americans with T2D-ESKD [rs41302867 P = 0.033 (OR = 0.50)], and a trend towards rs9379084 association was observed (P = 0.070). In European Americans with T2D-ESKD compared with European American population based controls, both RREB1 variants replicated association [rs9379084 P = 1.67 × 10(-4) (OR = 0.54) and rs41302867 P = 0.013 (OR = 0.69)]. Rs9379084 was not associated with non-T2D-ESKD or T2D in African Americans (P = 0.55 and P = 0.37, respectively), but was associated with T2D in European Americans (P = 0.014, OR = 0.65). In African Americans, rs41302867 was associated with non-T2D-ESKD [P = 0.036 (OR = 0.54)] and hypertension attributed ESKD [H-ESKD, P = 0.029 (OR = 0.50)]. A meta-analysis combining African American and European American T2D-ESKD data revealed P = 3.52 × 10(-7) and 3.70 × 10(-5) for rs9379084 and rs41302867 association, respectfully. A locus-wide analysis evaluating putatively functional SNPs revealed several nominal associations with T2D-ESKD, non-T2D-ESKD and T2D in African and European Americans. RREB1 is a large, complex gene which codes a multidomain zinc finger binding protein and transcription factor. We posit that variants in RREB1 modulate seemingly disparate phenotypes (i.e. T2D, T2D-ESKD and non-T2D-ESKD) through altered activity resulting from splice site and missense variants.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseAgedAlternative SplicingAngiotensinogenBlack or African AmericanCase-Control StudiesDiabetes Mellitus, Type 2DNA-Binding ProteinsFemaleGenetic LociGenome-Wide Association StudyHaplotypesHumansKidney Failure, ChronicMaleAGT protein, humanAngiotensinogenDNA-Binding ProteinsRREB1 protein, humanTranscription Factors

Identifiers

PMID25027322
PMCPMC4240197
OpenAlexW2154739626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.